Accelerate recruitment and ‘first patient in’ time

Streamlined user journeys help accelerate time to “first patient in” and get your trial up and running with minimal fuss.

Fully-integrated screening and consent enable faster set-up and enrollment. Our DeTAP atrial fibrillation trial recruited 94% of participants in less than two weeks and maintained an 86% retention rate.1

Powering digital-first clinical research




Connected devices

Seamless set up and go

Maximise participant sign-ups and minimise dropouts with an uninterrupted screening-to-consent process. Invite participants by email directly from the platform and get them up and running quickly with our easy-to-use, step-by-step onboarding module featuring efficient electronic ID verification.

Comprehensive support for multiple market recruitment strategies

The Huma platform is ready to deploy immediately in 80+ countries across the US, Europe, China, Middle East, Southeast Asia, and more. We’re device and cloud-agnostic for the widest possible global deployment flexibility.

We have the ability to recruit participants globally via sites, central participant hubs and recruitment marketing campaigns.

Regulatory, safety and compliance

CE 0297 icon.
EU MDR 2017/745 Class IIb certified

MHRA registered Medical Device Class IIb

US FDA icon.
21CFR820 US FDA Class II

US Food and Drug Administration Medical Device 510k # K230214

ISO icon.
ISO certifications

ISO 13485: 2016 certified (Medical Devices: Quality Management Systems)

ISO 27001: 2013 certified

Data protection - infosec icon.
Data protection / infosec

Committed to GDPR compliance

NHS Registration on Data Security and Protection Toolkit

CyberEssentials / CyberEssentials Plus

Request a meeting
This field is required.
This field is required.
This field/correct format is required.
This field is required.
This field is required.
Country / region *
This field is required.
I'm interested in
Request a meeting
Thank you.

We will be in touch with you shortly.

Request a meeting

Something went wrong while submitting the form.



Sarraju, A., Seninger, C., Parameswaran, V. et al. Pandemic-proof recruitment and engagement in a fully decentralized trial in atrial fibrillation patients (DeTAP). npj Digit. Med. 5, 80 (2022). https://doi.org/10.1038/s41746-022-00622-10